Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

378 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Elevated circulating level of β-aminoisobutyric acid (BAIBA) in heart failure patients with type 2 diabetes receiving sodium-glucose cotransporter 2 inhibitors.
Katano S, Yano T, Kouzu H, Nagaoka R, Numazawa R, Yamano K, Fujisawa Y, Ohori K, Nagano N, Fujito T, Nishikawa R, Ohwada W, Katayose M, Sato T, Kuno A, Furuhashi M. Katano S, et al. Among authors: furuhashi m. Cardiovasc Diabetol. 2022 Dec 20;21(1):285. doi: 10.1186/s12933-022-01727-x. Cardiovasc Diabetol. 2022. PMID: 36539818 Free PMC article.
Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population.
Fuseya T, Furuhashi M, Yuda S, Muranaka A, Kawamukai M, Mita T, Ishimura S, Watanabe Y, Hoshina K, Tanaka M, Ohno K, Akasaka H, Ohnishi H, Yoshida H, Saitoh S, Shimamoto K, Miura T. Fuseya T, et al. Among authors: furuhashi m. Cardiovasc Diabetol. 2014 Aug 21;13:126. doi: 10.1186/s12933-014-0126-7. Cardiovasc Diabetol. 2014. PMID: 25142635 Free PMC article.
Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy.
Furuhashi M, Sakuma I, Morimoto T, Higashiura Y, Sakai A, Matsumoto M, Sakuma M, Shimabukuro M, Nomiyama T, Arasaki O, Node K, Ueda S. Furuhashi M, et al. Cardiovasc Diabetol. 2020 Jun 15;19(1):89. doi: 10.1186/s12933-020-01061-0. Cardiovasc Diabetol. 2020. PMID: 32539832 Free PMC article. Clinical Trial.
A Resuscitated Case of Acute Myocardial Infarction with both Familial Hypercholesterolemia Phenotype Caused by Possibly Oligogenic Variants of the PCSK9 and ABCG5 Genes and Type I CD36 Deficiency.
Nishikawa R, Furuhashi M, Hori M, Ogura M, Harada-Shiba M, Okada T, Koseki M, Kujiraoka T, Hattori H, Ito R, Muranaka A, Kokubu N, Miura T. Nishikawa R, et al. Among authors: furuhashi m. J Atheroscler Thromb. 2022 Apr 1;29(4):551-557. doi: 10.5551/jat.58909. Epub 2021 Feb 27. J Atheroscler Thromb. 2022. PMID: 33642439 Free PMC article.
Involvement of necroptosis in contrast-induced nephropathy in a rat CKD model.
Shibata S, Moniwa N, Kuno A, Kimura A, Ohwada W, Sugawara H, Gocho Y, Tanaka M, Yano T, Furuhashi M, Tanno M, Miki T, Miura T. Shibata S, et al. Among authors: furuhashi m. Clin Exp Nephrol. 2021 Jul;25(7):708-717. doi: 10.1007/s10157-021-02048-1. Epub 2021 Mar 16. Clin Exp Nephrol. 2021. PMID: 33728555
378 results